NittoPhase^® solid support utilizes state-of-the-art polymer synthesis capabilities to provide a solid support for therapeutic oligonucleotide synthesis offering the highest available performance at a greatly reduced cost. The superior properties of Nitto's proprietary formulated cross-linked polystyrene structure deliver increased yields with greater purity at lower unit cost. NittoPhase^® thus delivers a positive impact on both the overall cost and quality of both small and large scale oligonucleotide synthesis.

Since its launch in 2005, NittoPhase^® has fast become the leading and most trusted solid support in the field of oligonucleotide therapeutics, as well as being widely used in research scale applications.

In addition to our standard deoxynucleoside loaded NittoPhase^®, Kinovate recently announced the launch of NittoPhase^® loaded with UnyLinker^TM, a universal linker developed by Isis Pharmaceuticals. UnyLinker is the most advanced and efficient universal linker currently on the market, delivering superior yields and purity with little or no process change and at a highly competitive cost.

For more information about NittoPhase^®, please refer to the technical resources below. For ordering, please contact Kinovate Life Sciences, Inc. on 1-866-258-3221.